Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Aldeyra Therapeutics Inc (NASDAQ: ALDX) was $4.7 for the day, down -3.69% from the previous closing price of $4.88. In other words, the price has decreased by -$3.69 from its previous closing price. On the day, 0.82 million shares were traded. ALDX stock price reached its highest trading level at $4.98 during the session, while it also had its lowest trading level at $4.67.
Ratios:
Our analysis of ALDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.68 and its Current Ratio is at 2.68. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 13 ’25 when Alfieri Michael bought 2,500 shares for $5.30 per share. The transaction valued at 13,250 led to the insider holds 2,500 shares of the business.
Machatha Stephen sold 22,073 shares of ALDX for $113,713 on Aug 11 ’25. The Chief Development Officer now owns 221,799 shares after completing the transaction at $5.15 per share. On Aug 12 ’25, another insider, Machatha Stephen, who serves as the Officer of the company, bought 22,074 shares for $5.26 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALDX now has a Market Capitalization of 282765024 and an Enterprise Value of 223011440.
Stock Price History:
The Beta on a monthly basis for ALDX is 0.85, which has changed by -0.101338446 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, ALDX has reached a high of $7.20, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is -9.42%, while the 200-Day Moving Average is calculated to be 3.06%.
Shares Statistics:
ALDX traded an average of 752.59K shares per day over the past three months and 1039290 shares per day over the past ten days. A total of 60.16M shares are outstanding, with a floating share count of 58.21M. Insiders hold about 3.25% of the company’s shares, while institutions hold 65.69% stake in the company. Shares short for ALDX as of 1763078400 were 5566535 with a Short Ratio of 7.40, compared to 1760486400 on 4682239. Therefore, it implies a Short% of Shares Outstanding of 5566535 and a Short% of Float of 9.54.
Earnings Estimates
The dynamic stock of Aldeyra Therapeutics Inc (ALDX) is currently being evaluated by a team of 3.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.15 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.55 and -$0.62 for the fiscal current year, implying an average EPS of -$0.59. EPS for the following year is $0.55, with 4.0 analysts recommending between $1.67 and -$0.43.
Revenue Estimates
Based on 6 analysts’ estimates, the company’s revenue will be $74.63M in the next fiscal year. The high estimate is $168M and the low estimate is $16M.
